Quick Information
- Category:
- Healthcare
- Pricing:
- Contact Sales
- Platforms:
- Web, Cloud, PACS integration
- Free Plan:
- No
- Last Verified:
- October 2026
What Is Qure.ai?
Qure.ai builds AI that reads medical images, mainly chest X-rays and head CT scans. Its chest X-ray product line is qXR, and its emergency head CT line is qER. Trade press reports FDA clearance for qER's detection of intracranial haemorrhage and for qER-Quant, which quantifies critical abnormalities on head CT. A 2023 510(k) clearance covered triage of pneumothorax and pleural effusion on chest X-rays as a passive notification for worklist prioritization, and separate clearances are reported for qXR-LN (lung nodules), qXR-CTR (cardiothoracic ratio) and qXR-BT (breathing tube placement).
Tuberculosis is where Qure.ai is most visible globally. Its qSpot-TB software holds an FDA breakthrough device designation, which is not the same as clearance. In October 2025 the company announced CE Class IIb certification for qXR in children aged 0 to 3, extending coverage for children up to 15. Most of this comes from company announcements and trade-press reprints, so verify each product's status and indications in the FDA 510(k) database. Pricing is not published, and deployments are quoted by site and volume.
Qure.ai suits hospitals, imaging networks and public health programmes that need scalable screening and triage, including in low-resource settings. Compare it with Aidoc, Lunit and Viz.ai. More options are in the Healthcare tools directory.
What Can You Use Qure.ai For?
Chest X-ray triage
Flags pneumothorax and pleural effusion and prioritizes the worklist.
Head CT in the emergency room
qER helps detect intracranial haemorrhage and quantify abnormalities.
Tuberculosis screening
qSpot-TB (breakthrough designation) and qXR support TB detection programmes.
Pediatric chest imaging
CE Class IIb certification for children aged 0 to 3.
Qure.ai Features
- qXR — AI reading of chest X-rays across several findings.
- qER and qER-Quant — Head CT detection and quantification.
- Lung nodule and CTR modules — qXR-LN and qXR-CTR for nodules and heart size.
- Worklist notification — Passive alerts that help prioritize urgent studies.
Who Is Qure.ai For?
- Hospital radiology teams — Triage chest and head scans faster.
- Public health programmes — Screen at scale for conditions such as TB.
Qure.ai Pros & Limitations
What We Like
- Broad portfolio across chest X-ray and head CT
- Multiple reported FDA clearances
- Global footprint including TB screening
Limitations
- No published pricing
- TB software has breakthrough designation, not FDA clearance
- Clearance details come mostly from company and trade press
Qure.ai Pricing
| Plan | Price | Main Features |
|---|---|---|
| Enterprise | Custom | qXR, qER and related modules priced by site and volume |
Pricing was last verified October 2026. Check the official website for the latest pricing.
AI Listing Jungle Ranking
- Global Rank:
- #1700
- Overall Score:
- 0.0/100
- Monthly Users:
- –
- Rank Change:
- ▼ 374
This ranking reflects AI Listing Jungle's own independent scoring methodology and is not an endorsement by Qure.ai or its company. How Our Rankings Work
Frequently Asked Questions
What does Qure.ai do?
It uses AI to analyse chest X-rays and head CT scans and flag urgent findings.
Is Qure.ai FDA cleared?
Several products have reported FDA clearances, including qER and chest X-ray triage tools. Check the FDA database for details.
Is the TB software FDA cleared?
Reports describe a breakthrough device designation for qSpot-TB, which is not a clearance.
How much does it cost?
Pricing is not public.
Our Take
Qure.ai has one of the widest imaging AI portfolios outside the big US names, and its global TB work is notable.
Verify each module's clearance and indications before relying on it.
Qure.ai Alternatives
Qure.ai Comparisons
Ready to try Qure.ai?
Visit the official website to get started.
Visit Official WebsiteAI Listing Jungle is an independent AI tools directory. Product names, logos, and trademarks belong to their respective owners.